Primal Health Databank: Study

Entry No:0202
Title:Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumour appearance in young women
Author(s):Herbst AL, Ulfelder H, Poskanzer DC
Reference:New Eng J Medicine 1971; 284(16): 878-881
Place of Study:USA
Abstract:Between 1966 and 1969, seven young women, 15-22 years of age, with adenocarcinoma of the vagina (clear cell or endometrial type) were seen at the Vincent Memorial Hospital. No such case in the younger age group had ever been seen at this institution before 1966. This led the authors to conduct a retrospective investigation in search of factors that might be associated with tumour appearance. Four match controls were established for each patient. It appeared that maternal bleeding during the current pregnancy and previous pregnancy loss were more common in the study group. Most significantly, seven of the eight mothers with carcinoma had been treated with diethylstilbestrol started in the first trimester. None in control group were so treated. Maternal ingestion of stilbestrol during early pregnancy appears to have enhanced the risk of vaginal carcinoma developing years later in the offspring exposed.
Keyword(s):cancer of the vagina, Diethylstilbestrol
Discussion:This is one of the first studies belonging to the framework of primal health research. It opened the way to other studies on the possible long term effects of drugs used during pregnancy on the offspring. See entry 0203. This is one of the first studies among humans suggesting that the chain of events leading to cancer can start in fetal life. See entry 0202.
See Also:0203

Go Back | New Keyword Search